Dr. Aravind'S Ivf Profile
Key Indicators
- Authorised Capital ₹ 2.25 M
as on 19-12-2024
- Paid Up Capital ₹ 2.25 M
as on 19-12-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.00 Cr
as on 19-12-2024
About Dr. Aravind'S Ivf
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.25 M and a paid-up capital of Rs 2.25 M.
The company currently has active open charges totaling ₹10.00 Cr.
Veluswamy Aravindchander and Ravichandran Reshmashri serve as directors at the Company.
- CIN/LLPIN
U85100TZ2022PTC040345
- Company No.
040345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2022
- Date of AGM
31 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr. Aravind'S Ivf?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veluswamy Aravindchander  | Director | 24-Nov-2022 | Current |
| Ravichandran Reshmashri | Director | 24-Nov-2022 | Current |
Financial Performance of Dr. Aravind'S Ivf.
Dr. Aravind'S Ivf Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr. Aravind'S Ivf?
Unlock access to Dr. Aravind'S Ivf's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Diya Women Private LimitedActive 5 years 1 monthVeluswamy Aravindchander and Ravichandran Reshmashri are mutual person
Dr A5 Pharma Private LimitedActive 1 month 4 daysVeluswamy Aravindchander and Ravichandran Reshmashri are mutual person
- Ifc Ivf Private LimitedActive 5 years 17 days
Veluswamy Aravindchander and Ravichandran Reshmashri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 19 Aug 2024 | ₹4.00 Cr | Open |
Others Creation Date: 31 Jul 2024 | ₹3.00 Cr | Open |
Others Creation Date: 31 Jul 2024 | ₹3.00 Cr | Open |
How Many Employees Work at Dr. Aravind'S Ivf?
Unlock and access historical data on people associated with Dr. Aravind'S Ivf, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Aravind'S Ivf, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Aravind'S Ivf's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
